The results included in this study pointed out that fecal Hb, together with CEs, could be a promising diagnostic tool that improves the accuracy of diagnosis compared to the use of fecal Hb only, mainly for CRC and CTRL. This evidence concerns the gene GSTM1 and colorectal carcinoma.